← Cases
JapanHealthcare and life sciences2023 – ongoing

Daiichi Sankyo

In-house generative AI system DS-GAI

Daiichi Sankyo launches in-house generative AI one month after project start; over 80% of survey respondents report gains

WorkingVendor's case studyVendor ↗

Problem

The Japanese drugmaker wanted employees to use generative AI safely, with a release targeted for September 2023.

Approach

Daiichi Sankyo worked with Avanade Japan and launched DS-GAI to all employees on September 1, 2023, without a proof-of-concept stage. GPT-4, document upload, image generation and a Code Interpreter function were added through February 2024.

Results

Over 80%Survey respondents saying it improved their productivity and accuracyVendor's case study[1]
About 600Employees using the system every dayVendor's case study[1]

Takeaway

More than half of group employees have used it at least once, and about 600 use it daily.

Categories

AI technology
Generative AI
Evidence
Vendor's case study

Sources

  1. Daiichi Sankyo customer story
    Microsoft2025Vendor publication

Source summaries

[1]Microsoft2025

Daiichi Sankyo built DS-GAI in one month and later added features. More than 80% of survey respondents reported gains in productivity and accuracy, and about 600 employees used it daily.

Full details are in the original sources.

Added 25 Oct 2026 · Updated 25 Oct 2026
Open case page ↗